ViVitro Labs Introduces World's first "Set it and forget it" Heart Valve Durability Tester
New Heart Valve Durability tester with Automatic Dual Control technology debuts at the 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.
"Introducing a New Generation of Durability Testers"
VICTORIA, BC, Sept. 16, 2022 /CNW/ - ViVitro Labs, the industry-leading provider of cardiovascular device test equipment and related consulting services, announces the launch of a revolutionary, self-regulating heart valve durability tester, the ViVitro Labs Heart Valve Durability Tester with ADC™ technology (https://vivitrolabs.com/product/adc-heart-valve-durability-tester/ ) at TCT 2022 in booth 542 on September 17-19, 2022, at the Boston Convention and Exhibition Center (BCEC)".
Heart Valve Durability Testers measure the longevity and performance of artificial heart valve prostheses in accelerated conditions to ensure devices are safe before being used in patients.
A multidisciplinary team of mechanical, electronic, and software engineers spent more than 3 years in R&D developing the device, drawing upon extensive experience in the field of cardiovascular device testing. The team incorporated feedback from industry leading cardiovascular device companies, start-ups, universities, testing labs, and consultants throughout the process.
The ViVitro Labs Heart Valve Durability Tester received enthusiastic praise during preliminary product evaluation demonstrations over the past 10 months from companies including Medtronic, Edwards, Abbott, and Boston Scientific.
Preliminary product evaluation feedback on two key features:
Independent standalone architecture with true independent test modules
"The truly independent nature of each station means downtime could be much less."
"I like dealing with the modularity. Distinct units that are separate and don't communicate with each other. You're not loading up the whole thing and can have 1 or all 6 going."
"Impressed by the standalone architecture. It's great for early-stage R&D when samples are scarce."
Chamber size and visibility
"I appreciate the visibility of the valve, the side views, and the visual from top and bottom."
"You can see all 6 chambers at the same time. In one look, you know if anything is wrong."
"I like the idea of having this chamber we could modify or put different things into."
Karim Mouneimne, President of ViVitro Labs Inc. and General Manager of Vivitro Labs SASU, explains a key benefit of the ADC™ technology, "This technology helps avoid over pressurizing and over opening valve samples during testing thus improving reliability and reducing costly false negative results.
I am thrilled to present our new Heart Valve Durability tester with Automatic Dual Control technology at TCT 2022 in booth 542 on September 17-19, 2022, at the Boston Convention and Exhibition Center (BCEC)."
About ViVitro Labs
ViVitro Labs Inc., Canada, offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 39 countries for 35 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro Labs products are manufactured by StarFish Medical in Victoria, Canada. (see our ISO 17925 scope of accreditation for Marseille, France and Victoria, Canada).
Former NFL Player’s Book Says Inclusive Competitiveness is Key to Future U.S. Economic Prosperity
Arlington, VA, September 16, 2022 — Some may only know Johnathan Holifield as a former Cincinnati Bengals running back, but since his stint in the NFL, he’s been anything but idle. Now senior vice president for new economies at Bitwise Industries, Holifield has gained important insight into America’s economic engine and why, he says, the country can’t win without strengthening at once inclusion and competitiveness.
Holifield’s vision of the future economy is achieving more with the goal of getting “all hands on deck.” According to his model, this will happen only by including disconnected Americans, such as women, African Americans, Latinos and rural populations, in America’s economic competitiveness priorities and no longer relegating their aspirations to less productive areas of the economy.
The book “offers a clear critique of how we got to such low productivity of underserved humans in the Innovation Economy,” Holifield said. “… and an even clearer, implementable path to achieving genuine economic inclusion and competitiveness.”
The Future Economy and Inclusive Competitiveness is an important read for anyone who is passionate about community transformation, generational wealth creation and U.S. competitiveness, and interested in a proven framework to make them happen.
Holifield’s unique background effectively carrying out inclusive competitiveness in the government and private sectors and more, has given him equally unique and actionable ideas. In regard to his early mover position, he says he “may be the first person to explicitly link improved U.S. global competitiveness to diversity, equity and inclusion.”
About the Author
Johnathan Holifield has worn many hats and carried many titles during his career. Dubbed the Architect of Inclusive Competitiveness, Holifield is currently the senior vice president for new economies at Bitwise Industries. The Future Economy and Inclusive Competitiveness: How Demographic Trends and Innovation Can Create Economic Prosperity for All Americans is his first book.
Holifield has over 20 years of diverse experience, effectively translating concepts into presidential policy, federal law, and organizational and local development strategies. He served as executive director of the White House initiative on Historically Black Colleges and Universities (HBCU). His other previous roles included vice president of inclusive competitiveness at NorTech, founding executive director of CindyTech and vice president of new economy enterprise at the Cincinnati USA Chamber.
Soaring Demand for Christian Hip-Hop Propels Rise of Holy Culture Radio
Wilmington, DE, September 16, 2022 — In April, Holy Culture Radio (HCR), a staple in the Christian hip-hop community, expanded to a full-time “edutainment” channel on SiriusXM Radio,broadening its reach into its faith-based rap audience.
“There has always been a question of whether there is a market for Christian hip-hop music,” said James Rosseau, founder of the nonprofit organization that operates HCR. “I believe our 5 million subscribers have shown that the genre has broad viability given the above average listener engagement we’ve seen across our 14 shows and music mixes as we play a wide diversity of Christian hip-hop artists.”
HCR’s programming features faith-based rap and rhythmic music from some of the biggest names and upcoming artists, a variety of DJ mixes, and empowering conversations intended to educate and inspire its audience.
“I am ecstatic at how God has moved in just over four months, allowing us to leverage our extended platform to share the voices of more than 300 artists with millions. Further, I could not be more proud of the HCR Squad — from our hosts and DJs, to the internal team, that is making it all happen!” Rosseau said.
With a focus on the themes of Faith, Arts, Vocation and Education (FAVE), Rosseau says that HCR provides a unifying blend of three factors important to its audience: connection to popular culture, connection to their faith and success in their careers.
“HCR acts as a megaphone/amplifier of awareness, a portal for tools, and the creation of a community and movement that helps people find their superpowers and learn how to activate them,” Rosseau said, adding that while the platform serves all, they are very focused on young African Americans.
Holy Culture Radio is owned and operated by The Corelink Solution, a nonprofit founded by Rosseau that delivers curriculums “to help people develop their passion and purpose, create an informed plan, use provided tools to help them succeed, and establish accountability and ownership.”
The Holy Culture brand aims to promote Christian values and lifestyle through media.
Holy Culture Radio can be heard on SiriusXM Channel 154.
Learn more at www.holyculture.net, or follow Holy Culture on Twitter (holyculture), Instagram (holyculture), YouTube (holyculture) Facebook (holyculturenet) and TikTok (@holyculture.net).
And save 10% on any sale going on now until the end of the month.
They have tons of options for whatever wall you are decorating!
I have also teamed up with WeCOOK again this month!
Use Code:
Trainitright70
To save on this amazing meal delivery service!
Also
I am accepting clients now:
Let me help you! Theres no better time than now to start!
Need help with training, nutrition and supplementation? I have online coaching slots available.
I can help! I now have client spots open....
SERIOUS INQUIRES ONLY.
I have helped hundreds of men and women achieve their goals not just for stage but through transformation/lifestyle coaching.
For anyone interested in coaching - I have limited spots available for prep, off-season and transformation left. So if you are serious about your goals.Contact me NOW or Sign Up HEREI also do ONLINE POSING for: BIKINI FIGURE WELLNESS MENS PHYSIQUEContact me NOW
Not interested in coaching but still want to support me and my sport....click HERE Thanks so much!
CloudMD’s TAiCBT Results in Significant Improvement for PTSD Across Symptom Severity Levels, Trauma Types and Demographics
Recent research study demonstrates that the majority of clients experience reliable improvement in symptoms after just two months of treatment
VANCOUVER, British Columbia, Sept. 15, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, today released a research study that demonstrates the positive outcome results from using its therapist-led internet based cognitive behavioural therapy (TAiCBT) for individuals suffering from posttraumatic stress disorder (PTSD) across symptom severity levels, trauma types and demographics.
PTSD is a debilitating condition often exacerbated by long wait times and lack of access to effective treatment. The first line psychological treatments for PTSD are rooted in principles of cognitive behavioural therapy (CBT). Digital delivery of these therapies represents an opportunity to improve access to evidence-based treatment that can reduce symptoms of posttraumatic stress.
CloudMD recently completed its study to determine the effectiveness of its TAiCBT for posttraumatic stress and examine how pre-treatment client characteristics are related to key outcomes. The sample consisted of individuals with histories of traumas ranging from experiencing sexual assault to observing work-related suffering; this enabled researchers to also explore the relationship between these diverse histories and treatment outcomes.
Highlights of Results:
Between January 2020 and June 2022, 4,236 people consented to treatment for symptoms of posttraumatic stress, and 3,689 of those completed at least one post assessment outcome measure.
Clients reported significant symptoms: 96% reported symptoms that exceeded the threshold for being a clinical case and 68% also reported serious symptoms of depression and anxiety, as well as impaired functioning in day-to-day activities.
Clients reported a range of trauma histories: 68% reported ‘other unwanted or uncomfortable sexual experience’, 59% reported physical assault, 56% reported sexual assault, 36% reported a transportation accident, and 54% reported ‘other very stressful event’.
When broken down by gender, unwanted sexual experiences and assaults (both physical and sexual) were the most reported experiences for women. For men, the most reported traumatic experiences were physical assaults, other stressful experiences or a transportation accident.
On average, clients started treatment within 7 calendar days of submitting an assessment, with 71% of treatment content completed outside of standard work hours.
The CloudMD treatment had a large and statistically significant effect on clients’ posttraumatic stress symptoms and a moderate effect on symptoms of depression, anxiety and functional impairment.
Most clients achieved significant symptom reduction with the percent increasing as clients complete more treatment content: 61% of clients who engage with the trauma-focused content experience a reliable improvement in their symptoms, and 77% who engage with the consolidation content experience reliable improvement with an average reduction of 23 points on the PTSD Checklist for DSM-5.
Treatment was effective for the full range of symptom scores. Clients with higher baseline trauma symptom scores were more likely to achieve reliable symptom improvement than those with lower scores.
All client types were equally likely to achieve reliable symptom improvement: demographic characteristics and trauma type were not predictive of engagement with treatment or of symptom change.
Most studies of TAiCBT for PTSD focus on specific subsets of the population, such as groups that are assumed to have employment-related exposure to trauma, including members of the military (or veterans), first-line responders (EMTs, ER physicians), or law enforcement (Straud et al 2019; Stephanopoulou et al 2020). Given that interpersonal trauma – such as physical and sexual assault – accounts for a large proportion of PTSD cases (Bedoya et al., 2020), research on the effectiveness of TAiCBT for posttraumatic stress would benefit from expanding the field of study to include broader populations, which is exactly what this study does.
In addition to evaluating the efficacy of CloudMD’s posttraumatic stress treatment protocol to determine whether accessible, low-intensity treatment options would be effective for posttraumatic stress across the full spectrum of symptom severity, CloudMD’s researchers also explored the effect of sample-specific factors on treatment outcomes. Researchers examined whether pre-treatment client characteristics such as gender, age, and trauma type, predicted differential response to treatment.
“This study solidifies the importance of offering therapy for posttraumatic stress alongside depression and anxiety therapy to complement care and provide truly effective treatment for anyone needing trauma support, not only the first-responder community,”shared Karen Adams, President and CEO, CloudMD.“Our data allows for better understanding of the conditions and the impact of targeted treatments. This helps employers make informed choices when they evaluate workplace mental health investments by equipping them with critical insights,”she continued.
The study demonstrates the basic effectiveness of CloudMD’s TAiCBT program for posttraumatic stress in a real-world heterogenous sample of help-seeking individuals. More than half of clients experienced significant reduction in trauma symptoms; 38% of clients experienced reductions in depression and anxiety; and 28% of clients reported improvements in day-to-day functioning. The program led to reductions in symptoms for clients across the range of symptom severity. While the longer a client spent engaged in treatment, the greater their likelihood of achieving symptom improvement, many clients who did not complete all phases of therapy experienced reliable symptom improvement. These results indicate that offering low-intensity treatment for posttraumatic stress is a viable and frequently sufficient entry point to care.
“Our TAiCBT program enables us to break down barriers to evidence-based care that many individuals experience, such as lack of accessible or specific treatments. We’ve been able to successfully treat clients with varying severity of post traumatic symptoms,”said Dr. Leorra Newman, Clinical Content Lead, CloudMD. “This study highlights that targeting post traumatic symptoms directly can lead to associated improvements in levels of anxiety, depression, and functioning - making a true difference in our clients’ lives,” Newman added.
Accessing evidence-based mental health treatment in a timely manner is challenging, taking 25 business days in Canada to access typical community-based services, with wait times for specific conditions like PTSD reaching approximately two years. This lack of accessibility is a significant problem for individuals, their families, employers and many other parts of society. CloudMD provides timely access to TAiCBT within days of a completed assessment, accelerating access, providing support outside regular office hours, and alleviating demand on traditional pathways.
Furthermore, the effectiveness of CloudMD’s programs showcases the value of selecting evidence-based mental health treatment for HR leaders investing in the well-being of their staff. As shown in this study, CloudMD has a proven, highly effective treatment for people with diverse histories of trauma and demographic characteristics.
CloudMD will be hosting a webinar to discuss the research on September 28th, 2022 at 9am PT/12pm ET as part of its Better Outcomes Initiative. Individuals can register for it here: Better Outcomes Webinar Registration.
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company’s fastest growing division. CloudMD’s Enterprise Health Solutions Division has built a leading employer healthcare solutions, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a direct ecosystem of over 5,700 clinicians including, 1,800+ mental health practitioners, 1,600+ allied health professionals, 1,400+ doctors and nurses and covers 12 million individual lives across North America. For more information visit: https://investors.cloudmd.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
“Karen Adams” Chief Executive Officer
Ultimate Anti-aging Rêvolution - Firming Redensifying Mask Announced as a top-performing Face Mask in 2022 Clean Beauty Awards
MONTREAL, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Zorah biocosmétiques’ Ultimate Anti-aging Rêvolution – Firming Redensifying Mask has been named winner of the Face Mask Category in CertClean’s 7th annual Clean Beauty Awards. The esteemed Clean Beauty Awards were created to acknowledge and reward superior beauty and personal care products formulated without the use of harmful chemicals by trailblazers in the clean beauty market.
More than 450 best-selling, clean beauty products were nominated for this year’s awards and were judged by an international panel of 146 beauty specialists. Finalists/Winners/Top3 were chosen in each of the 24 product categories.
“I am so grateful that our Rêvolution anti-aging mask has won first place in the face mask category. Our team worked really hard to develop this amazing product!
We were able to combine the great virtues of silver powder, organic argan oil and other natural ingredients to come up with this anti-aging, hydrating and soothing face mask.”Mélissa Harvey – Zorah Biocosmétiques Founder & CEO.
The RÊVolution ultimate anti-aging mask with pure silver firms and tightens the skin, providing intense hydration for mature skin. Used for thousands of years, pure silver has healing, purifying, soothing and anti-aging properties. This face mask was designed to nourish and help restore skin’s radiance, suppleness and vivacity.
RÊVolution Ultimate anti-aging cream – Finalist in the face cream category One of Zorah's bestsellers! This hydrating, firming and plumping treatment was designed for sensitive mature skin. A large quantity of pure silver, which has been used for thousands of years in alternative medicine, is in this treatment to provide healing, purifying, soothing and anti-aging properties.
About Zorah Biocosmétiques
Founded 15 years ago following a humanitarian trip in Morrocco, Zorah is a high-performance, argan oil based, 100% natural skin care brand.
Zorah is now a well-established company in Quebec and Canada, with more than 1,000 points of sale (Jean Coutu, Brunet, Rachel Berry and other independent retailers) and recently launched on the Shoppers Drug Mart online store.
For more information visit zorah.ca and follow Zorah on Facebook and Instagram @zorahbiocosmetiques.
About Clean Beauty Awards
Established in 2015, the Clean Beauty Awards is the leading awards program honouring excellence in clean beauty and personal care products. The 7th annual Clean Beauty Awards received 455 entries from Canada, the US, Australia and throughout Europe.
Coveo Survey Reveals 45% of Consumers Will Start Holiday Shopping Earlier Than Past Holiday Peak Periods in Search of Deals Given Rising Costs
Survey also found that consumer shopping is not slowing down despite economic concerns, with 80% of consumers planning to shop as much or more this holiday season as compared to last year
MONTREAL and LONDON and SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Coveo (TSX:CVO), a leader in relevance platforms that helps to transform search, recommendations, and personalization within digital experiences, today announced a new report titled, 2022 Holiday Shopping Report: Spending Trends & Impact, which unveils findings from a summer 2022 survey of 4,000 U.S. and U.K. consumers. Conducted by Coveo in partnership with Arlington Research, the report provides analysis of shopper sentiment and plans for the upcoming holiday season and reveals surprising trends and macro and microeconomic factors impacting this holiday shopping season.
A large majority of respondents (80%) said that they plan to shop the same or more during the upcoming holiday season compared with past years. Interestingly, nearly one in two shoppers (45%) said they will start their shopping earlier than usual to find deals and discounts given the rising cost and availability of goods.
“Despite the rising cost of living, we continue to see strong interest in shopping for the upcoming holidays, though brands should note the anticipated behavioral changes related to shopping timeframes, generational mindsets, and expectations for intertwined online-offline customer experiences,” Brian McGlynn, General Manager of commerce at Coveo. “As economic conditions continue to fluctuate, we believe retailers must keep up with shopper behavior trends and test assumptions to keep the customer experiences relevant at all times and the focus on profitability and performance will be even more necessitated.”
The survey unveiled several insights on current shopper sentiment and behavior trends, including:
Having a physical retail presence may help with ecommerce sales: While 54% of consumers said they are likely to look at a product online and buy it in-store, an almost identical number (53%) reported being likely to look at a product in-store and buy it online. Physical stores driving growth across allchannels will continue throughout 2022, according to multiple retail experts.
Uncertain logistics and restrictive return policies negatively impact conversions: Abandonment and bounce rates are always significant challenges for retailers, and according to Coveo’s survey, 42% of shoppers explicitly said they will leave a site if shipping options are limited or they don’t have a buy online pick-up in store option (BOPIS). Also noteworthy is that 35% of respondents said they are turned off by restrictive returns policies.
Generational differences in shopping attitudes with Gen Z as main standout: There were notable patterns across different generations that retailers should prepare for as the seasonal peaks approach. Specifically, when asked about brands between this year and last, compared to other generations, Gen Z is more apt to buy luxury goods online (28% vs. 15% overall), more loyal to brands they shopped last year (41% vs. 23% overall), and more likely to factor sustainability into buying decisions (64% vs. 25% overall).
Brand loyalty continues to reign, especially with older generations: Millennials (58%), Gen Xers (67%), Baby Boomers (75%), and the Silent Generation (77%) all stayed loyal to the brands they liked in the last year.
Motivating factors go beyond discounts: Approximately two-thirds (67%) of people surveyed this summer are interested in product recommendations, tailored offers, discounts, and promotions. This, combined with the likelihood of spreading out purchases to take advantage of deals, means retailers should note that although many consumers are shopping more online, it may be more challenging to translate the interest into a higher Average Order Value (AOV).
For complete results of the consumer survey, please download the report here.
About Coveo Solutions
We believe that relevance and personalization are critical for businesses to win in the new digital experience economy, to serve people the way they expect, and that applied AI is an imperative. Coveo is a market-leading AI-powered relevance platform. Our SaaS-native, multi-tenant platform injects search, recommendations, and personalization solutions into digital experiences. We provide solutions for commerce, service, website, and workplace applications. Our solutions are designed to provide tangible value to our customers by helping drive conversion and revenue growth, increase profitability, reduce customer support costs, increase customer satisfaction and website engagement, and improve employee proficiency and satisfaction. Coveo is a trademark of Coveo Solutions, Inc.
Stay up to date on the latest Coveo news and content by subscribing to the Coveo blog, and following Coveo on LinkedIn, Twitter, and YouTube.
Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth
TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced changes to its management team and structure designed to further position the Company for continued sales success and global growth.
Abbey Goodman and Hartmut Warnken have been appointed Chief Commercial Officer – U.S. and Chief Commercial Officer – OUS, respectively, with each having overall responsibility for leading Profound’s commercial strategy, sales, sales operations, and marketing activities in their corresponding geographies. They succeed Kenneth Knudson, who is leaving the Company.
“We thank Ken for his contributions to the growth and development of the Company, and wish him the best for the future,” Profound’s CEO and Chairman, Arun Menawat. “At the same time, we are excited that he is leaving our commercial organization in such good hands. In the second quarter of this year, the team achieved the first-ever North American sales of Sonalleve® systems, and we saw increased adoption of TULSA-PRO®. That positive momentum has continued so far in Q3-2022. We remain on track to add five new TULSA-PRO® system installations this quarter, and to reach our total U.S. installed base goal of 35 systems by the end of the year.”
Ms. Goodman brings over 17 years of medical device sales experience, most recently serving as Profound’s VP, U.S. Sales & Marketing. Prior to joining the Company in June 2019, she progressed through a variety of senior sales leadership roles with Hologic, Inc., Novadaq Technologies Inc., Covidien Plc (now Medtronic plc), and DePuy Mitek, Inc. Ms. Goodman earned a BS in Biological Engineering from Louisiana State University.
Mr. Warnken has over 20 years of experience in the medical technology industry. Before joining Profound in November 2015 as VP, International Sales & Marketing, he served as VP & General Manager Europe, Middle East, Japan and Asia Pacific, Managing Director/Officer for IMRIS Pte. Ltd., IMRIS Germany GmbH and IMRIS KK Japan. Prior to IMRIS, Mr. Warnken held two positions at BrainLAB AG. He holds an MBA from ESCP-Europe Business School.
Profound also announced that Michael Mydra, who leads Profound’s reimbursement activities as VP, Head of Global Market Access, will now report directly to Dr. Menawat.
“Securing a CPT® Category 1 code for TULSA remains a strategic imperative over the longer-term and, to that end, we expect to submit an updated application to the American Medical Association at the appropriate time in 2023,” said Dr. Menawat. “Michael is well qualified to help us manage this process. He joined us from Boston Scientific, where he was the VP of Global Market Access and Reimbursement for all of the company’s urologic products. Prior to that, he led reimbursement strategies at Augmenix, which developed the SpaceOAR device to reduce side effects associated with prostate cancer.”
About Profound Medical Corp.
Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.
Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO® is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum to help preserve the patient’s natural functional abilities. TULSA-PRO® has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer, and the transition zone in large volume benign prostatic hyperplasia (“BPH”). TULSA-PRO® is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (“FDA”).
Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve® has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve® where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.
Forward-Looking Statements
This release includes forward-looking statements regarding Profound and its business which may include, but is not limited to, the expectations regarding the efficacy of Profound’s technology in the treatment of prostate cancer, BPH, uterine fibroids, palliative pain treatment and osteoid osteoma. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of Profound. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, regulatory approvals, reimbursement, economic factors, the equity markets generally and risks associated with growth and competition. Although Profound has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. In addition, there is uncertainty about the spread of the COVID-19 virus and the impact it will have on Profound’s operations, the demand for its products, global supply chains and economic activity in general. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Profound undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, other than as required by law.
RIFF Cannabis Brand Launches ‘Drumsticks’
New Limited-Edition Infused Pre-Rolls Now Available Across Ontario, Canada
TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced that its Canadian cannabis brand, RIFF, launched Drumsticks, a new premium, infused pre-roll with amplified THC potency and fruit-forward aromas.
Specially produced in limited quantities, RIFF Drumsticks are made with Granddaddy Purp whole flower, featuring grape and berry aromas, rolled in unbleached paper, dipped in sticky distillate, and coated in a bed of kief to provide the ultimate elevated RIFF experience. Coupled with a high THC potency, these infused pre-rolls march to their own beat.
“We’re excited to launch new innovative products that hit home for cannabis consumers looking for products that taste good and provide a heightened experience,” said Kyle Asselstine, RIFF Brand Manager. “RIFF is a brand dedicated to perfecting the art of cannabis and we can’t wait to share our upcoming releases.”
RIFF Drumsticks are now available across Ontario.
About RIFF
RIFF was borne out of the love for a good joint effort. To us, creativity comes from pushing boundaries: seeing ideas from different perspectives, from new angles, and from a collection of collaborative endeavors. RIFF celebrates the joy of connecting with others and encouraging our community to create something meaningful, for infinite reinvention.
Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
For more information on Tilray, visit Tilray Brands, Inc. and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
Zen Rohatsu Invites Readers to Follow Buddha’s Path to Enlightenment
Philadelphia, PA, Sept. 14, 2022 — Could an ancient practice hold the key to dealing with today’s stressors? Zen meditation practitioner Nora D’Ecclesis opens her new book, Zen Rohatsu, with a guided visualization that places readers at the time of the Buddha, under the sacred fig tree, as he sought to obtain enlightenment.
“Buddha was a man who found his enlightenment and set his path, avoiding suffering by controlling his thoughts and desires,” wrote D’Ecclesis. “He was not and is not considered a deity.”
And with this historical perspective into how the concept of Buddhist enlightenment emerged, D’Ecclesis sets the stage for Zen Rohatsu, which provides thoroughly researched insights into the origins of meditation, its rituals and the ways in which living mindfully can be transformative. Included are simple meditation techniques, such as postures, breathing exercises and the use of mala beads.
Written for anyone wanting to cultivate a deeper sense of mindfulness and spirituality — from beginners to advanced meditation practitioners — Zen Rohatsu guides readers down the proverbial path of enlightenment.
“Zen Rohatsu is a microcosm of Zen meditation which best explains why we meditate and why most should consider this spiritual practice,” D’Ecclesis said. “I sat to outline a story about my spiritual practice, which I wrote from the memory of my own experiences as a lay meditator. The result is this book.”
The book explains that Rohatsu is a spiritual practice of meditative zazen that occurs on the eighth day of the twelfth month on the Gregorian calendar. The meditation sessions, which focus on Zazen Meditation rather than scriptures or rituals, are celebrated for seven days in advance of December 8 by Zen practitioners all over the world. Zen Rohatsu will help readers understand this type of meditation and how it might help them.
D’Ecclesis also added: “Zazen, a Japanese style dating back to the Buddha, is a meditation that keeps us in the present with focus, equanimity and stress management by clearing our thoughts from the various anxieties that permeate them. We turn off the chatter in our own heads and establish a place of compassion. We all experience interoceptive responses to the stressors and suffering and even the great joys in life, as all sentient beings do, so the balance of meditation and concept of equanimity are a welcome alternative.”
Nora D’Ecclesis is an American bestselling nonfiction author and Haiku poet. Her international No.1 bestseller The Retro Budget Prescription held the top spot in Kindle book downloads for the business/self-help category for over a year. She is a graduate of Kean University of New Jersey with post graduate degrees in administration and education. Her other published nonfiction includes Amazon No. 1 bestseller Haiku: Natures Meditation and paperbacks/eBooks on such topics as time management, guided visualizations, gratitude/equanimity, journaling and Zen meditation.
For more information about the author, visit https://noradecclesis.com/, or follow her on Twitter at @DECCLESIS or on Facebook at NoraDEcclesis.
